CN104862314A - 一种与α-鹅膏毒肽特异结合的核酸适配体及应用 - Google Patents
一种与α-鹅膏毒肽特异结合的核酸适配体及应用 Download PDFInfo
- Publication number
- CN104862314A CN104862314A CN201510234400.3A CN201510234400A CN104862314A CN 104862314 A CN104862314 A CN 104862314A CN 201510234400 A CN201510234400 A CN 201510234400A CN 104862314 A CN104862314 A CN 104862314A
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- aptame
- aptamer
- amanita hemolysin
- amanita
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000039446 nucleic acids Human genes 0.000 title abstract description 7
- 108020004707 nucleic acids Proteins 0.000 title abstract description 7
- 150000007523 nucleic acids Chemical class 0.000 title abstract description 7
- 101800002638 Alpha-amanitin Proteins 0.000 title abstract description 4
- RXGJTYFDKOHJHK-UHFFFAOYSA-N S-deoxo-amaninamide Natural products CCC(C)C1NC(=O)CNC(=O)C2Cc3c(SCC(NC(=O)CNC1=O)C(=O)NC(CC(=O)N)C(=O)N4CC(O)CC4C(=O)NC(C(C)C(O)CO)C(=O)N2)[nH]c5ccccc35 RXGJTYFDKOHJHK-UHFFFAOYSA-N 0.000 title abstract description 4
- 239000004007 alpha amanitin Substances 0.000 title abstract description 4
- CIORWBWIBBPXCG-SXZCQOKQSA-N alpha-amanitin Chemical compound O=C1N[C@@H](CC(N)=O)C(=O)N2C[C@H](O)C[C@H]2C(=O)N[C@@H]([C@@H](C)[C@@H](O)CO)C(=O)N[C@@H](C2)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@H]1C[S@@](=O)C1=C2C2=CC=C(O)C=C2N1 CIORWBWIBBPXCG-SXZCQOKQSA-N 0.000 title abstract description 4
- CIORWBWIBBPXCG-UHFFFAOYSA-N alpha-amanitin Natural products O=C1NC(CC(N)=O)C(=O)N2CC(O)CC2C(=O)NC(C(C)C(O)CO)C(=O)NC(C2)C(=O)NCC(=O)NC(C(C)CC)C(=O)NCC(=O)NC1CS(=O)C1=C2C2=CC=C(O)C=C2N1 CIORWBWIBBPXCG-UHFFFAOYSA-N 0.000 title abstract description 4
- 229960005502 α-amanitin Drugs 0.000 title abstract description 4
- 239000002773 nucleotide Substances 0.000 claims abstract description 8
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 8
- 108091023037 Aptamer Proteins 0.000 claims description 50
- 108010006464 Hemolysin Proteins Proteins 0.000 claims description 46
- 239000003228 hemolysin Substances 0.000 claims description 46
- 230000009870 specific binding Effects 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 abstract description 22
- 108090000790 Enzymes Proteins 0.000 abstract description 8
- 102000004190 Enzymes Human genes 0.000 abstract description 8
- 238000005516 engineering process Methods 0.000 abstract description 8
- 108091034117 Oligonucleotide Proteins 0.000 abstract description 5
- 108091081406 G-quadruplex Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000002594 sorbent Substances 0.000 abstract 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 17
- 239000007788 liquid Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 102000053602 DNA Human genes 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000000872 buffer Substances 0.000 description 8
- 230000008878 coupling Effects 0.000 description 8
- 238000010168 coupling process Methods 0.000 description 8
- 238000005859 coupling reaction Methods 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 108020004682 Single-Stranded DNA Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 6
- 235000020958 biotin Nutrition 0.000 description 6
- 239000011616 biotin Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 239000011735 vitamin B7 Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 229930003756 Vitamin B7 Natural products 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 108091008104 nucleic acid aptamers Proteins 0.000 description 5
- 235000011912 vitamin B7 Nutrition 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 239000012148 binding buffer Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 2
- WVHGJJRMKGDTEC-WCIJHFMNSA-N 2-[(1R,4S,8R,10S,13S,16S,27R,34S)-34-[(2S)-butan-2-yl]-8,22-dihydroxy-13-[(2R,3S)-3-hydroxybutan-2-yl]-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide Chemical compound CC[C@H](C)[C@@H]1NC(=O)CNC(=O)[C@@H]2Cc3c([nH]c4cc(O)ccc34)[S@](=O)C[C@H](NC(=O)CNC1=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1C[C@H](O)C[C@H]1C(=O)N[C@@H]([C@@H](C)[C@H](C)O)C(=O)N2 WVHGJJRMKGDTEC-WCIJHFMNSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 241000134916 Amanita Species 0.000 description 2
- 241000948559 Amanita fuliginea Species 0.000 description 2
- 231100000729 Amatoxin Toxicity 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 108010016076 Octreotide Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 108010014709 amatoxin Proteins 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229940072272 sandostatin Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- GUYIZQZWDFCUTA-UHFFFAOYSA-N (pentadecachlorophthalocyaninato(2-))-copper Chemical compound [Cu+2].N1=C([N-]2)C3=C(Cl)C(Cl)=C(Cl)C(Cl)=C3C2=NC(C2=C(Cl)C(Cl)=C(Cl)C(Cl)=C22)=NC2=NC(C2=C(Cl)C(Cl)=C(Cl)C(Cl)=C22)=NC2=NC2=C(C(Cl)=C(C(Cl)=C3)Cl)C3=C1[N-]2 GUYIZQZWDFCUTA-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 108010027164 Amanitins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102000009572 RNA Polymerase II Human genes 0.000 description 1
- 108010009460 RNA Polymerase II Proteins 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- CIORWBWIBBPXCG-JZTFPUPKSA-N amanitin Chemical compound O=C1N[C@@H](CC(N)=O)C(=O)N2CC(O)C[C@H]2C(=O)N[C@@H](C(C)[C@@H](O)CO)C(=O)N[C@@H](C2)C(=O)NCC(=O)N[C@@H](C(C)CC)C(=O)NCC(=O)N[C@H]1CS(=O)C1=C2C2=CC=C(O)C=C2N1 CIORWBWIBBPXCG-JZTFPUPKSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000010206 sensitivity analysis Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510234400.3A CN104862314B (zh) | 2015-05-11 | 2015-05-11 | 一种与α‑鹅膏毒肽特异结合的核酸适配体及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510234400.3A CN104862314B (zh) | 2015-05-11 | 2015-05-11 | 一种与α‑鹅膏毒肽特异结合的核酸适配体及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104862314A true CN104862314A (zh) | 2015-08-26 |
CN104862314B CN104862314B (zh) | 2017-12-01 |
Family
ID=53908490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510234400.3A Active CN104862314B (zh) | 2015-05-11 | 2015-05-11 | 一种与α‑鹅膏毒肽特异结合的核酸适配体及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104862314B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10111966B2 (en) | 2016-06-17 | 2018-10-30 | Magenta Therapeutics, Inc. | Methods for the depletion of CD117+ cells |
CN111308100A (zh) * | 2020-04-13 | 2020-06-19 | 北京维德维康生物技术有限公司 | 一种检测β-鹅膏毒肽的酶联免疫试剂盒及其制备和应用 |
CN117843727A (zh) * | 2024-03-07 | 2024-04-09 | 内蒙古大学 | 环肽毒素α-Amanitin和/或Amaninamide的制备方法、中间体及应用 |
CN117949664A (zh) * | 2023-11-20 | 2024-04-30 | 云南师范大学 | 一种检测毒蘑菇的免洗电化学发光生物传感器的制备方法及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102234648A (zh) * | 2011-06-09 | 2011-11-09 | 中国人民解放军第三军医大学第一附属医院 | 一种与弓形虫病毒具有特异性的弓形虫抗体适配子及构成的生物芯片 |
CN103013999A (zh) * | 2012-11-22 | 2013-04-03 | 江南大学 | 一组特异识别伏马菌素b1的寡核苷酸适配子 |
-
2015
- 2015-05-11 CN CN201510234400.3A patent/CN104862314B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102234648A (zh) * | 2011-06-09 | 2011-11-09 | 中国人民解放军第三军医大学第一附属医院 | 一种与弓形虫病毒具有特异性的弓形虫抗体适配子及构成的生物芯片 |
CN103013999A (zh) * | 2012-11-22 | 2013-04-03 | 江南大学 | 一组特异识别伏马菌素b1的寡核苷酸适配子 |
Non-Patent Citations (3)
Title |
---|
云雯等: "基于核酸适配体的生物传感技术在食品安全领域中的研究进展", 《食品工业科技》 * |
王丽等: "核酸适体及其在食品安全领域的应用", 《安徽科技学院学报》 * |
陈作红等: "我国28种鹅膏菌主要肽类毒素的检测分析", 《菌物系统》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10111966B2 (en) | 2016-06-17 | 2018-10-30 | Magenta Therapeutics, Inc. | Methods for the depletion of CD117+ cells |
CN111308100A (zh) * | 2020-04-13 | 2020-06-19 | 北京维德维康生物技术有限公司 | 一种检测β-鹅膏毒肽的酶联免疫试剂盒及其制备和应用 |
CN111308100B (zh) * | 2020-04-13 | 2023-04-21 | 北京维德维康生物技术有限公司 | 一种检测β-鹅膏毒肽的酶联免疫试剂盒及其制备和应用 |
CN117949664A (zh) * | 2023-11-20 | 2024-04-30 | 云南师范大学 | 一种检测毒蘑菇的免洗电化学发光生物传感器的制备方法及应用 |
CN117843727A (zh) * | 2024-03-07 | 2024-04-09 | 内蒙古大学 | 环肽毒素α-Amanitin和/或Amaninamide的制备方法、中间体及应用 |
CN117843727B (zh) * | 2024-03-07 | 2024-07-02 | 内蒙古大学 | 环肽毒素α-Amanitin和/或Amaninamide的制备方法、中间体及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104862314B (zh) | 2017-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113151282B (zh) | 结合新型冠状病毒(SARS-CoV-2)核衣壳蛋白的核酸适配体及其用途 | |
Arakaki et al. | Formation of magnetite by bacteria and its application | |
Li et al. | Development of a magnetic nanoparticles microarray for simultaneous and simple detection of foodborne pathogens | |
CN104862314A (zh) | 一种与α-鹅膏毒肽特异结合的核酸适配体及应用 | |
CN103884847B (zh) | 一种结核分枝杆菌全蛋白质芯片及应用 | |
SE500262C2 (sv) | Ett förbättrat sätt för analys av nukleinsyror, en reagenskombination och en utrustning därför | |
CN105039346A (zh) | 一种与三聚氰胺特异结合的核酸适配体及应用 | |
CN103898203B (zh) | 微小隐孢子虫的检测方法及检测试剂盒 | |
CN104745588B (zh) | 一种特异识别链霉素的核酸适配子及其在链霉素检测中的应用 | |
JP2018516533A5 (zh) | ||
Oehler et al. | Affinity Selections of DNA‐Encoded Chemical Libraries on Carbonic Anhydrase IX‐Expressing Tumor Cells Reveal a Dependence on Ligand Valence | |
JP2007525982A5 (zh) | ||
RU2011143788A (ru) | Способ детектирования анти-sith-1 антитела в биологическом образце | |
CN101236209A (zh) | 基于生物芯片检测核酸结合蛋白-靶标蛋白之间是否存在相互作用的方法 | |
CN107462714A (zh) | 与吊白块特异结合的核酸适配体Sf‑A09及其应用 | |
CN107505463A (zh) | 与吊白块特异结合的核酸适配体Sf‑B09及其应用 | |
CN103108959A (zh) | 用于从包括成分血的含纤维蛋白原的样品中分离目标分子或颗粒的方法 | |
CN105177009A (zh) | 一种与α-鹅膏毒肽特异结合的核酸适配体及应用 | |
CN101970690A (zh) | 一种检测隐孢子虫的方法 | |
CN103451316A (zh) | 用于检测建兰花叶病毒的引物、试剂盒及检测方法 | |
CN105177011A (zh) | 一种与瘦肉精特异结合的核酸适配体及应用 | |
CN105039347A (zh) | 一种与草甘膦特异结合的核酸适配体及应用 | |
CN105255931A (zh) | 一种基于细菌表面展示系统的病毒受体捕获体系 | |
CA2498951A1 (en) | Method for enriching procaryotic dna | |
JP2006204241A (ja) | 分子モータシステムとその応用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Han Qinqin Inventor after: Qiao Pu Inventor after: Li Jie Inventor after: Xia Xueshan Inventor after: Song Yuzhu Inventor after: Zhang Jinyang Inventor after: Chen Qiang Inventor before: Han Qinqin Inventor before: Qiao Pu Inventor before: Song Yuzhu Inventor before: Zhang Jinyang Inventor before: Chen Qiang |
|
GR01 | Patent grant | ||
GR01 | Patent grant |